Trial intelligence / Profile preview

Effect of Propofol on Remifentanil-induced Hyperalgesia in Thyroid Surgery

NCT01189721Phase 4Unknown

Sponsor
Gangnam Severance Hospital
Start
Aug 2010
Primary completion
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of propofol injection (veterinary) in hyperalgesia (2 arms), sponsored by Gangnam Severance Hospital. Primary endpoint: Tactile pain thresholds adjacent to the surgical wound assessed by von Frey hair at 48 hours. Status: unknown.

02

Drugs

propofol injection (veterinary)
03

Conditions

hyperalgesia

Beyond the preview

Go deeper on NCT01189721.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01189721.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call